A business in context
WGS research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-17 | Fuchs Thomas | M · Exercise / conversion | Class A Common Stock | 1146.0 | 0.0 |
| 2026-09-17 | Fuchs Thomas | M · Exercise / conversion | Restricted Stock Unit | 1146.0 | 0.0 |
| 2026-09-16 | Feeley Kevin | M · Exercise / conversion | Class A Common Stock | 7197.0 | 0.0 |
| 2026-09-16 | Feeley Kevin | S · Sale | Class A Common Stock | 586.0 | 94.26 |
| 2026-09-16 | Feeley Kevin | S · Sale | Class A Common Stock | 1079.0 | 99.0 |
| 2026-09-16 | Feeley Kevin | S · Sale | Class A Common Stock | 541.0 | 96.9 |
| 2026-09-16 | Feeley Kevin | S · Sale | Class A Common Stock | 1470.0 | 98.27 |
| 2026-09-16 | Feeley Kevin | S · Sale | Class A Common Stock | 52.0 | 95.41 |
| 2026-09-16 | Feeley Kevin | M · Exercise / conversion | Restricted Stock Unit | 7197.0 | 0.0 |
| 2026-09-16 | Stueland Katherine | S · Sale | Class A Common Stock | 4141.0 | 98.27 |
| 2026-09-16 | Stueland Katherine | S · Sale | Class A Common Stock | 1525.0 | 96.9 |
| 2026-09-16 | Stueland Katherine | S · Sale | Class A Common Stock | 148.0 | 95.41 |
| 2026-09-16 | Stueland Katherine | S · Sale | Class A Common Stock | 1648.0 | 94.26 |
| 2026-09-16 | Stueland Katherine | M · Exercise / conversion | Class A Common Stock | 18750.0 | 0.0 |
| 2026-09-16 | Stueland Katherine | S · Sale | Class A Common Stock | 3039.0 | 99.0 |
| 2026-09-16 | Stueland Katherine | M · Exercise / conversion | Restricted Stock Unit | 18750.0 | 0.0 |
| 2026-09-09 | Feeley Kevin | M · Exercise / conversion | Class A Common Stock | 2462.0 | 0.0 |
| 2026-09-09 | Feeley Kevin | S · Sale | Class A Common Stock | 1285.0 | 84.22 |
| 2026-09-09 | Feeley Kevin | M · Exercise / conversion | Restricted Stock Unit | 2462.0 | 0.0 |
| 2026-09-09 | Stueland Katherine | M · Exercise / conversion | Class A Common Stock | 6547.0 | 0.0 |
| 2026-09-09 | Stueland Katherine | S · Sale | Class A Common Stock | 3692.0 | 84.22 |
| 2026-09-09 | Stueland Katherine | M · Exercise / conversion | Restricted Stock Unit | 6547.0 | 0.0 |
| 2026-09-01 | Feeley Kevin | S · Sale | Class A Common Stock | 372.0 | 83.84 |
| 2026-09-01 | Feeley Kevin | M · Exercise / conversion | Class A Common Stock | 717.0 | 0.0 |
| 2026-09-01 | Feeley Kevin | M · Exercise / conversion | Restricted Stock Unit | 717.0 | 0.0 |
| 2026-06-29 | GARDNER MARK A | A · Grant / award | Restricted Stock Unit | 35441.0 | 0.0 |
Identity & relationships
SEC issuer · 0001818331GeneDx Holdings Corp.
Search names and former names
- Sema4 Holdings Corp. · former SEC name · 2021-06-02 to 2023-01-05
- CM Life Sciences, Inc. · former SEC name · 2020-07-23 to 2021-07-21
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $305.45M | $328.08M |
| 2023-12-31 | $202.57M | $223.98M |
| 2022-12-31 | $234.69M | $270.16M |
| 2021-12-31 | $212.19M | $263.81M |
| 2020-12-31 | $179.32M | $233.45M |
| 2019-12-31 | $196.17M | $258.53M |